TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
HUMA

Humacyte Inc

Healthcare · Biotechnology

0.5573$ -2.0% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement HUMA
Line item 2019 2020 2021 2022 2023 2024 2025
– -75.9% -15.3% +23.9% -100.0% – –
– -28.5% +13.4% -86.5% +827.3% -90.6% +137.1%
– – – – – – –
– -28.5% +13.4% +3.1% +21.0% +15.7% -21.8%
– -27.1% +77.3% +8.8% +2.2% +10.3% +20.8%
– -26.2% +75.9% +268.6% -69.8% +356.3% -13.8%
– – – – – – –
– -4.2% +97.5% +42.6% +6.4% +40.6% +21.3%
– – – – – – –
– – -3,007.0% – – – –
– – – – – – –
– – – – -4,045.1% – –

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?